RecruitingPhase 3NCT07654374
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Las Vegas, NV · +73 more sites
Type 2 Diabetes clinical trials in Las Vegas, NV
14 recruiting type 2 diabetes studies with a site in Las Vegas, NV.
RecruitingPhase 2NCT07527650
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Sponsor: Hanmi Pharmaceutical Company Limited
Las Vegas, NV · +19 more sites
RecruitingPhase 3NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Sponsor: Boehringer Ingelheim
Las Vegas, NV · +205 more sites
RecruitingPhase 2NCT07589608
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Sponsor: Eli Lilly and Company
Las Vegas, NV · +39 more sites
RecruitingPhase 2NCT07783802
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Sponsor: Eli Lilly and Company
Las Vegas, NV · +28 more sites
RecruitingPhase 3NCT07776509
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Las Vegas, NV · +22 more sites
RecruitingPhase 3NCT07321886
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
Las Vegas, NV · +40 more sites
RecruitingPhase 3NCT07743450
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Sponsor: Ascletis Pharma (China) Co., Limited
Las Vegas, NV · +83 more sites
RecruitingPhase 3NCT07662213
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Henderson, NV · Las Vegas, NV · +62 more sites
RecruitingPhase 3NCT07662135
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Sponsor: AstraZeneca
Las Vegas, NV · +32 more sites
RecruitingPhase 3NCT07662044
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Las Vegas, NV · +26 more sites
RecruitingPhase 3NCT07784725
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Las Vegas, NV · +32 more sites
RecruitingPhase 2NCT07502508
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Sponsor: Biomea Fusion Inc.
Las Vegas, NV · +16 more sites
RecruitingPhase 2NCT07546929
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Sponsor: Housey Healthcare ULC
Las Vegas, NV · +24 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.